Vitamin D Deficiency: The Most Common Nutritional Gap in 2026

Vitamin D occupies a peculiar position among nutrients. It is technically a prohormone, not a vitamin. The body can synthesize it from sunlight, making dietary intake theoretically optional. And yet, by every population-level measure available, insufficiency and outright deficiency are staggeringly common. The NIH estimates that approximately 35% of American adults have serum 25-hydroxyvitamin D levels below 20 ng/mL — the threshold for deficiency — and an additional 40% fall below 30 ng/mL, the level many endocrinologists consider insufficient. Globally, the numbers are even higher. An estimated one billion people have inadequate vitamin D status, making it the single most prevalent nutritional gap in the world.

Why Deficiency Is Structural, Not Behavioral

The standard explanation for vitamin D deficiency — people do not spend enough time outside — is true but incomplete. The modern epidemic of low vitamin D is better understood as the collision of human biology with contemporary living conditions that it was not designed for.

Latitude. Ultraviolet B radiation, the wavelength that drives cutaneous vitamin D synthesis, is absorbed by the atmosphere at oblique angles. Above approximately 37 degrees north latitude — a line that runs through San Francisco, Athens, and Seoul — UVB intensity is insufficient to produce meaningful vitamin D synthesis for roughly four to six months of the year. During a Boston winter, a person could stand outside for hours without producing a single microgram of vitamin D, regardless of skin exposure. This affects the majority of the population in North America, Europe, northern Asia, and the southern portions of South America and Oceania.

Skin pigmentation. Melanin absorbs UVB radiation. Darker skin provides superior protection against UV-induced DNA damage and folate degradation — a significant evolutionary advantage in equatorial environments — but requires substantially longer sun exposure to produce the same amount of vitamin D. Estimates suggest that a person with deeply pigmented skin may need 5-10 times more sun exposure than a person with light skin to achieve equivalent vitamin D synthesis. In populations that have migrated from equatorial to northern latitudes, this mismatch is a primary driver of deficiency.

Indoor living and sun protection. Glass blocks UVB. Sunscreen with SPF 30 reduces vitamin D synthesis by approximately 95%. Office workers, even those living at favorable latitudes, may receive minimal UVB exposure on a typical workday. The public health recommendation to avoid unprotected sun exposure — which has been effective in reducing skin cancer incidence — simultaneously and unavoidably reduces vitamin D production.

Aging. The skin’s capacity to synthesize vitamin D declines with age. A 70-year-old produces approximately 25% of the vitamin D that a 20-year-old produces from the same duration of sun exposure. This combines with reduced outdoor activity, institutional living, and decreased dietary variety to make older adults the demographic group most consistently and severely affected by vitamin D deficiency.

Obesity. Vitamin D is fat-soluble and is sequestered in adipose tissue. Individuals with higher body fat percentage have lower circulating 25-hydroxyvitamin D levels even when total body stores are adequate, because the vitamin is trapped in fat deposits and unavailable for metabolic use. This is not a deficiency of intake but a deficiency of bioavailability, and it partially explains the consistent association between obesity and low measured vitamin D status.

What Vitamin D Actually Does

Vitamin D’s best-established role is in calcium and phosphorus homeostasis. It promotes intestinal calcium absorption, maintains serum calcium and phosphate concentrations sufficient for bone mineralization, and regulates osteoclast and osteoblast activity. Severe deficiency causes rickets in children and osteomalacia in adults — conditions characterized by impaired bone mineralization that are entirely preventable with adequate vitamin D status.

Beyond bone, vitamin D receptors are expressed in virtually every tissue in the human body, including immune cells, cardiac myocytes, pancreatic beta cells, and neurons. This widespread expression has fueled an enormous body of observational research linking low vitamin D status to outcomes far beyond skeletal health: cardiovascular disease, type 2 diabetes, multiple sclerosis, depression, autoimmune conditions, and cancer.

The observational evidence is extensive. Whether it is causal is a different question.

The Causation Problem

A 2014 systematic review in The Lancet Diabetes and Endocrinology examined the totality of vitamin D supplementation trials and concluded that low vitamin D status is more likely a marker of ill health than a cause of it. Conditions that reduce sun exposure, physical activity, and dietary quality — chronic illness, obesity, aging, institutionalization — also reduce vitamin D levels. The association between low vitamin D and disease may reflect shared risk factors rather than a direct causal pathway.

Large randomized controlled trials have largely supported this interpretation. The VITAL trial, which randomized over 25,000 adults to vitamin D3 (2,000 IU/day) or placebo and followed them for a median of 5.3 years, found no significant reduction in the incidence of cardiovascular events or invasive cancer in the vitamin D group. The D-Health trial in Australia, with over 21,000 participants, found no effect of monthly high-dose vitamin D supplementation on all-cause mortality.

These null results do not mean vitamin D is unimportant. They mean that supplementing people who are already replete does not provide additional benefit — which is exactly what you would expect if vitamin D’s primary role is to prevent deficiency-related pathology rather than to enhance health above the sufficiency threshold. The distinction between treating deficiency and optimizing already-adequate levels is critical, and the supplement industry has systematically blurred it.

Practical Assessment and Correction

The standard biomarker for vitamin D status is serum 25-hydroxyvitamin D, measured in nanograms per milliliter (ng/mL) or nanomoles per liter (nmol/L). The Endocrine Society defines deficiency as below 20 ng/mL (50 nmol/L) and insufficiency as 21-29 ng/mL (52.5-72.5 nmol/L). Levels above 30 ng/mL are generally considered sufficient for bone health, though debate continues about whether higher levels (40-60 ng/mL) confer additional benefits.

For individuals with documented deficiency, the standard treatment protocol involves a loading dose — typically 50,000 IU of ergocalciferol (vitamin D2) weekly for 8 weeks — followed by maintenance supplementation of 800-2,000 IU of cholecalciferol (vitamin D3) daily. Vitamin D3 is preferred for maintenance because it is more effective at raising and sustaining serum 25-hydroxyvitamin D levels than D2.

Dietary sources of vitamin D are limited. Fatty fish (salmon, mackerel, sardines) provide 400-1,000 IU per serving. Cod liver oil provides approximately 1,360 IU per tablespoon. Fortified milk and orange juice provide 100-150 IU per cup. Egg yolks contain roughly 40 IU each. It is difficult to achieve adequate vitamin D status from diet alone, particularly for individuals with limited sun exposure, which is why supplementation is recommended for most adults living above 37 degrees latitude during winter months.

What a Reasonable Approach Looks Like

The vitamin D conversation has been polarized between two unhelpful extremes: dismissal of supplementation as unnecessary and promotion of megadoses as a cure for everything from depression to cancer. The evidence supports neither position.

For the approximately 35-40% of the adult population with serum levels below 20 ng/mL, correcting deficiency with supplementation is well-supported by evidence and carries minimal risk at standard doses. For individuals with levels above 30 ng/mL, there is no convincing evidence that additional supplementation improves any clinical outcome. The toxicity threshold — above which hypercalcemia and renal damage can occur — begins at serum levels around 150 ng/mL, which is difficult to reach with standard supplementation but not impossible with the megadose protocols promoted by some alternative health practitioners.

The most evidence-based recommendation is unglamorous: most adults in northern latitudes should take 1,000-2,000 IU of vitamin D3 daily during months when UVB synthesis is insufficient, and have their levels checked if they belong to high-risk groups (dark skin, obesity, elderly, limited sun exposure, malabsorption disorders). This is not a wellness strategy. It is the correction of a structural mismatch between human photobiology and modern living conditions.

James Okonkwo is the Metabolic Health Editor at Daily Bite Lab. He holds a PhD in Cardiovascular Nutrition from King’s College London.